Most psychiatric medications clear from your bloodstream within a few days to a couple of weeks after your last dose, but the actual timeline varies enormously depending on which drug you’re taking, your body’s metabolism, and what “out of your system” means to you. A fast-clearing antidepressant like sertraline behaves very differently from fluoxetine, whose active breakdown products can linger for weeks. And even after the drug itself is gone from your blood, its effects on brain chemistry can persist much longer. The gap between “drug cleared from plasma” and “brain back to baseline” is one of the least understood and most practically important distinctions in psychiatry.
Why Half-Life Is the Number That Matters
The standard way pharmacologists measure how long a drug sticks around is its elimination half-life: the time it takes for the concentration in your blood to drop by half. After one half-life, half the drug remains. After two, a quarter. After about five half-lives, the drug is considered essentially gone, with less than 3% of the original amount left circulating. This five-half-life rule gives you a rough estimate of total clearance time for any medication, as long as you know its half-life.1StatPearls Publishing. Elimination Half-Life of Drugs
The catch is that psychiatric medications span an enormous range. Some have half-lives measured in hours; others are measured in days. And some produce active metabolites, breakdown products that are themselves pharmacologically active and have their own, sometimes longer, half-lives. So “how long until it’s out” depends on which drug, at what dose, in whose body.
Antidepressants Have the Widest Spread
Among the SSRIs, fluoxetine is the clear outlier. The drug itself has a half-life of two to four days, but its active metabolite norfluoxetine hangs around for one to two weeks. Using the five-half-life rule, that means traces of norfluoxetine can remain in your system for roughly four to ten weeks after your last pill.2PubMed. Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability This is why psychiatrists sometimes use fluoxetine as a “bridge” when switching medications; its slow fade provides a kind of built-in taper.
Other SSRIs clear much faster. Paroxetine, sertraline, citalopram, and fluvoxamine all have half-lives of roughly one day, meaning they’re mostly gone within a week of stopping. Among these shorter-acting SSRIs, paroxetine and fluvoxamine are broken down into inactive products, so once the parent drug is gone, there’s nothing pharmacologically active left behind.3PubMed. SSRI differentiation: Pharmacology and pharmacokinetics SNRIs like venlafaxine also clear quickly, with a half-life under a day, which is part of why venlafaxine has such a notorious reputation for withdrawal symptoms when you miss even a single dose.
Tricyclic antidepressants are older medications that are still prescribed for certain conditions, and they tend to have half-lives in the range of one to three days at normal doses. But overdose situations reveal how dramatically clearance can change. In one pediatric case involving amitriptyline, drug levels remained dangerously elevated on day seven and were still detectable on day ten, far longer than the normal half-life would predict. Contributing factors included high body weight and possible drug interactions from cannabinoid use, which can interfere with the liver enzymes responsible for breaking down the medication.4PubMed Central. Prolonged Tricyclic Antidepressant Toxicity in a Pediatric Patient: The Importance of Understanding the Multifactorial Nature of Amitriptyline Metabolism
Benzodiazepines Range from Hours to Days
Benzodiazepines fall into rough categories based on how quickly they’re eliminated. Short-acting drugs like triazolam and oxazepam have half-lives of around five to twelve hours, meaning they’re mostly cleared within a couple of days. Long-acting benzodiazepines like diazepam are a different story. Diazepam itself has a half-life that often exceeds 24 hours, and its main metabolite, desmethyldiazepam, can persist even longer. These long-acting drugs accumulate substantially when taken regularly, which means full clearance after stopping can take weeks.5PubMed Central. Benzodiazepines: a summary of pharmacokinetic properties
This distinction between short-acting and long-acting benzodiazepines has real consequences for how withdrawal feels. Rebound anxiety and insomnia tend to appear within one to four days of stopping, with the timing closely tied to the half-life of the specific drug.6PubMed. The benzodiazepine withdrawal syndrome People taking short-acting benzodiazepines experience withdrawal symptoms earlier than those on long-acting ones, and the peak severity typically hits around day two for short-acting drugs versus four to seven days for long-acting drugs.7JAMA Psychiatry. Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation This pattern makes intuitive sense: the faster the drug drops out of your system, the more abruptly your brain has to adjust.
Antipsychotics Linger in the Brain Longer Than in the Blood
Antipsychotic medications present a particularly tricky case because their blood levels and their brain activity don’t move in lockstep. Risperidone, for instance, has a plasma half-life of about 18 hours, meaning the drug clears from your blood relatively quickly. But its occupancy of dopamine receptors in the brain has a half-life of roughly 80 hours, more than four times longer.8PubMed. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics In practical terms, this means that even after the drug is essentially undetectable in a blood draw, it’s still sitting on brain receptors and exerting effects.
This disconnect between blood clearance and brain clearance is one reason stopping antipsychotics abruptly can be risky. Withdrawal syndromes, rebound symptoms, and psychotic relapse can all occur after discontinuation, and relapse sometimes doesn’t happen until months after the medication is stopped.9PubMed Central. Stopping and switching antipsychotic drugs The drug may be “out of your system” by any measurable standard, but the brain hasn’t finished readjusting.
Researchers have proposed that tapering antipsychotics should follow a hyperbolic pattern, with dose reductions getting smaller and smaller as you approach zero. The rationale is that the relationship between dose and receptor blockade isn’t linear: cutting from 10 mg to 5 mg changes receptor occupancy much less than cutting from 2 mg to zero. Suggested tapering schedules involve reducing by about a quarter of the current dose every three to six months.10Schizophrenia Bulletin. A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse That’s a strikingly long timeline and reflects how slowly the brain recalibrates even after the medication itself is pharmacologically gone.
Discontinuation Symptoms Are Not the Same as Drug Presence
One of the most common confusions people have is conflating “how long the drug takes to leave” with “how long I’ll feel different after stopping.” These are related but distinct timelines. The drug might clear your blood in a week, but the neurochemical adjustments your brain made while you were on it can take much longer to reverse.
For antidepressants, the risk of withdrawal symptoms is strongly linked to half-life. A large analysis of adverse event reports found that antidepressants with short half-lives were about five times more likely to be associated with withdrawal syndrome compared to long-half-life antidepressants.11PubMed. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database This explains the well-known phenomenon of “brain zaps,” dizziness, and irritability with drugs like paroxetine and venlafaxine, which clear fast and leave the brain scrambling to compensate. Fluoxetine’s ultra-long half-life essentially tapers itself, which is why it’s associated with fewer discontinuation problems.
For benzodiazepines, withdrawal symptoms appeared earlier and more acutely with short-acting drugs, while long-acting benzodiazepines produced a more delayed and sometimes more drawn-out withdrawal course.12PubMed. Withdrawal reaction after long-term therapeutic use of benzodiazepines Either way, the withdrawal timeline extends well beyond the point when a blood test would show the drug is gone.
Your Body Composition Changes the Math
Many psychiatric medications are fat-soluble, meaning they dissolve readily into fatty tissue. When you take these drugs long-term, they accumulate in fat stores throughout your body and then slowly leach back into the bloodstream after you stop. This is why two people taking the same dose of the same medication can have very different clearance times.
In older adults, body fat percentage tends to increase even if overall weight stays stable. This leads to greater accumulation of fat-soluble drugs like diazepam and a longer elimination period after the last dose. On top of that, liver drug-processing capacity decreases by roughly 10 to 40 percent in older individuals for most medications studied.13PubMed Central. Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults The combination of more drug stored in tissue and slower metabolic breakdown means elderly patients can take substantially longer to clear a psychiatric medication than younger adults. Both decreased kidney and liver clearance and an increased volume of distribution for fat-soluble drugs contribute to this prolonged elimination.14PubMed Central. Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review
Obesity also extends the washout period. In people with higher BMI, the half-life of fat-soluble drugs is prolonged because there’s simply more tissue for the drug to hide in. This has clinical safety implications for how long drug levels stay elevated after chronic dosing ends.15PubMed. Effect of lipophilicity on drug distribution and elimination: Influence of obesity A study of patients undergoing benzodiazepine detoxification found that elimination duration was positively correlated with BMI, and obese patients required an additional 8 to 11 days of monitored care compared to their leaner counterparts. The effect was modest in terms of the overall variance it explained, but in a clinical detox setting, an extra week or more of medical supervision is a meaningful difference.16PubMed Central. Longer Duration of Drug Elimination and Withdrawal Symptoms in Overweight Patients Undergoing Detoxification for Benzodiazepine Dependence
Genetics and Liver Enzymes
Your genes play a role in how quickly you metabolize psychiatric drugs, though the picture is more nuanced than direct-to-consumer genetic testing companies sometimes suggest. The liver enzymes most relevant to psychiatric medication breakdown belong to the cytochrome P450 family, and genetic variations in these enzymes create a spectrum of metabolizer types. Some people break drugs down unusually fast (ultra-rapid metabolizers), some at a typical rate, and some very slowly (poor metabolizers).17PubMed Central. Pharmacogenomic Testing in Child and Adolescent Psychiatry: An Evidence-Based Review
One study of psychiatric patients who experienced adverse drug effects found that 44% of their CYP2D6 gene copies carried variants associated with inactive enzyme expression, more than double the rate seen in patients without side effects or in the general population.18PubMed. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry If you’re a poor metabolizer, drugs that rely on that enzyme for breakdown will hang around longer and reach higher concentrations, increasing both the duration of their presence and the risk of side effects.
That said, the evidence connecting genetic metabolizer status to real-world outcomes with SSRIs specifically is weaker than you might expect. A review of the data found that in patients at steady state on an SSRI, the existing evidence didn’t clearly show that metabolizer status predicted SSRI blood levels, how well the drug worked, or how well patients tolerated it.19Genetics in Medicine. Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors This doesn’t mean genetics are irrelevant to drug clearance. They clearly affect how fast the liver processes a given compound. But the translation from “this enzyme works slower” to “you’ll have a meaningfully different clinical experience” is less straightforward than a pharmacogenomics pamphlet might imply.
Drug Interactions Can Slow Everything Down
If you’re taking more than one medication, one drug can interfere with the liver enzymes responsible for breaking down another. This is especially relevant in psychiatry, where combinations of antidepressants, antipsychotics, mood stabilizers, and anti-anxiety drugs are common.
The SSRIs themselves are major offenders here. Paroxetine and fluoxetine are potent inhibitors of CYP2D6, a key enzyme for metabolizing several antipsychotics including haloperidol and risperidone. Taking fluoxetine alongside one of these antipsychotics can raise antipsychotic blood levels by blocking the enzyme that would normally clear them. Fluvoxamine, meanwhile, powerfully inhibits CYP1A2, which is the main route for clearing clozapine. This interaction is well-documented and clinically significant. SSRIs can also slow the clearance of benzodiazepines: fluoxetine increases levels of alprazolam and diazepam by inhibiting the enzymes that break them down.20PubMed. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence
From the antipsychotic side, the same principle applies. While newer antipsychotics don’t usually interfere with other drugs’ elimination, adding an enzyme inhibitor or inducer to the mix can change their clearance dramatically. Fluvoxamine’s interaction with clozapine is considered one of the most clinically important drug interactions in psychiatry.21PubMed. Metabolic drug interactions with newer antipsychotics: a comparative review The practical upshot: if you’re on multiple psych meds and you stop one that was inhibiting an enzyme, the remaining drugs may suddenly clear faster, potentially dropping below effective levels. Conversely, adding a new medication that inhibits an enzyme can slow clearance of your existing drugs and push their levels dangerously high.
Pregnancy and Surgical Changes
Pregnancy dramatically alters how the body handles psychiatric medications. Blood volume increases, liver metabolism ramps up, and kidney filtration speeds up. These changes tend to accelerate drug clearance, meaning the same dose produces lower blood levels than it did before pregnancy. Doses may need to be increased during pregnancy to maintain effectiveness, and then reduced again after delivery when the body returns to its pre-pregnancy state.22PubMed Central. Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles
Bariatric surgery creates a different kind of challenge. Procedures like gastric bypass rearrange the digestive tract, reducing the area available for drug absorption, changing stomach acidity, and speeding up how fast food and medications move through the gut. For a drug like fluoxetine, which relies on specific sections of the small intestine for optimal absorption, bypass surgery can reduce how much of the drug gets into the bloodstream in the first place.23PubMed Central. Changes in Antidepressant Absorption After Metabolic Bariatric Surgery This doesn’t directly answer “how long until the drug is out,” but it affects how much drug was ever in your system to begin with, which in turn shapes the elimination timeline.
A Quick Reference for Common Drug Classes
Pulling together the approximate clearance windows based on the five-half-life rule, here’s what you can generally expect after stopping each class of psychiatric medication. These are rough ranges for healthy adults at standard doses, and individual variation can push these numbers in either direction.
- Most SSRIs: With half-lives of roughly one day, drugs like sertraline, paroxetine, and citalopram are mostly eliminated within five to seven days.
- Fluoxetine: Because of its long-lived active metabolite norfluoxetine, full clearance takes roughly four to ten weeks.
- Venlafaxine: Clears quickly, within two to three days, but withdrawal effects can appear within hours of a missed dose.
- Short-acting benzodiazepines: Drugs like lorazepam and oxazepam clear within one to three days.
- Long-acting benzodiazepines: Diazepam and its active metabolites can take one to three weeks to fully clear.
- Antipsychotics: Blood clearance of drugs like risperidone takes a few days, but receptor occupancy in the brain can persist for weeks, and the clinical effects of stopping can emerge months later.
- Tricyclic antidepressants: Typically clear within one to two weeks, but this can extend substantially in overdose situations or in individuals with slower metabolism.
These numbers assume you’re not elderly, not obese, not taking enzyme-inhibiting medications, and don’t carry genetic variants that slow metabolism. In real life, many patients check more than one of those boxes, which is why the textbook half-life can underestimate the true clearance time by days or even weeks.
When “Out of Your System” Isn’t the Right Question
People usually ask this question for practical reasons. Maybe you’re planning to switch medications and want to know when the old one will be gone. Maybe you’re trying to get pregnant and want to minimize fetal exposure. Maybe you’re just tired of side effects and want to know when they’ll finally stop. In each case, the question that actually matters isn’t when the last molecule disappears, but when the drug stops having a meaningful effect on your body.
For that question, plasma clearance can be misleading. As the risperidone receptor data shows, a drug can be pharmacologically active in the brain long after it’s gone from the blood. For antidepressants, the neuroadaptation your brain underwent during months or years of treatment doesn’t reverse the moment the drug leaves. The serotonin system, the norepinephrine system, the receptor densities that shifted to accommodate the drug’s constant presence: all of these take time to rebalance, and that rebalancing process is what produces discontinuation symptoms. The drug is gone, but the brain hasn’t gotten the memo yet.
This is also why abrupt cessation is almost universally discouraged for psychiatric medications taken long-term. Gradual tapering doesn’t change how fast the drug leaves your blood. What it does is give the brain time to readjust incrementally rather than all at once. For antipsychotics, the recommended taper can stretch over months to years. For antidepressants, weeks to months is typical. The taper is treating the brain’s adjustment timeline, not the drug’s clearance timeline, and the two are frequently on very different schedules.